Gantonoc, Gerve B.

HRN: 18-29-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2024
CEFTRIAXONE 1G (VIAL)
08/08/2024
08/15/2024
IV
2g
Q25
Severe TBI Sec To MVA
Waiting Final Action 
08/08/2024
OXACILLIN 500MG (VIAL)
08/08/2024
08/15/2024
IV
2g
Q6h
TBI SEVER
Waiting Final Action 
08/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/08/2024
08/15/2024
IVT
500mg
Q8h
Traumatic Brain Injury
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: